CNS:NYE-Cohen & Steers Inc (USD)

EQUITY | Asset Management | New York Stock Exchange

Last Closing

USD 91.61

Change

+2.15 (+2.40)%

Market Cap

USD 1.61B

Volume

0.24M

Analyst Target

USD 72.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Cohen & Steers Inc is an investment manager engaged in real assets, including real estate, infrastructure and commodities, along with preferred securities and other income solutions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Asset Management

Symbol Name Price(Change) Market Cap
BX Blackstone Group Inc

+0.49 (+0.32%)

USD 167.48B
BLK BlackRock Inc

+9.34 (+1.04%)

USD 132.60B
KKR KKR & Co LP

+1.43 (+1.13%)

USD 107.17B
BN Brookfield Corp

-0.09 (-0.18%)

USD 76.06B
APO Apollo Global Management LLC C..

+0.63 (+0.54%)

USD 66.73B
ARES Ares Management LP

+3.41 (+2.28%)

USD 46.76B
AMP Ameriprise Financial Inc

+7.09 (+1.59%)

USD 43.71B
OWL Blue Owl Capital Inc

+0.17 (+0.94%)

USD 24.29B
RJF Raymond James Financial Inc.

+0.95 (+0.79%)

USD 24.28B
STT-PG State Street Corporation

+0.02 (+0.08%)

USD 19.16B

ETFs Containing CNS

CP9:PA Amundi Index MSCI Pacific.. 5.35 % 0.00 %

+4.70 (+0.08%)

USD 0.31B
18MM:F Amundi Funds - Amundi Ind.. 5.35 % 0.00 %

+3.60 (+0.08%)

N/A
18MM:XETRA Amundi Index MSCI Pacific.. 5.35 % 0.00 %

+0.20 (+0.08%)

USD 0.32B
MPXG:LSE Amundi Index MSCI Pacific.. 5.29 % 0.00 %

+42.75 (+0.08%)

N/A
CIB0:XETRA VanEck Bionic Engineering.. 4.81 % 0.00 %

+0.08 (+0.08%)

USD 6.22M
CP9U:PA Amundi MSCI Pacific ex Ja.. 4.61 % 0.00 %

+4.80 (+0.08%)

USD 0.03B
APXJ:XETRA Amundi Index MSCI Pacific.. 4.61 % 0.00 %

+0.07 (+0.08%)

USD 0.62B
CYBG:LSE VanEck Bionic Engineering.. 4.25 % 0.00 %

+0.09 (+0.08%)

N/A
FAIR:AU BetaShares Australian Sus.. 4.06 % 0.00 %

+0.11 (+0.08%)

USD 1.50B
MTUM:AU Betashares Australian Mom.. 3.30 % 0.00 %

+0.02 (+0.08%)

N/A
FDHT 3.01 % 0.00 %

N/A

N/A
OZXX:AU Global X Australia Ex Fin.. 3.00 % 0.00 %

+0.03 (+0.08%)

N/A
BATF:XETRA L&G Asia Pacific ex Japan.. 2.71 % 0.00 %

+0.06 (+0.08%)

N/A
DGRS WisdomTree U.S. SmallCap .. 2.26 % 0.38 %

+0.61 (+0.08%)

USD 0.39B
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.24 % 0.00 %

+0.02 (+0.08%)

N/A
EX20:AU BetaShares Australian Ex-.. 2.20 % 0.00 %

+0.06 (+0.08%)

USD 0.27B
DES WisdomTree U.S. SmallCap .. 0.68 % 0.38 %

+0.29 (+0.08%)

USD 2.01B
WELP:LSE HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

+4.90 (+0.08%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Asset Management) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.97% 93% A 85% B
Dividend Return 2.34% 10% F 49% F
Total Return 23.31% 87% B+ 85% B
Trailing 12 Months  
Capital Gain 43.59% 99% N/A 91% A-
Dividend Return 3.67% 14% F 51% F
Total Return 47.26% 99% N/A 91% A-
Trailing 5 Years  
Capital Gain 70.56% 96% N/A 80% B-
Dividend Return 27.50% 42% F 81% B-
Total Return 98.06% 96% N/A 85% B
Average Annual (5 Year Horizon)  
Capital Gain 5.93% 83% B 59% D-
Dividend Return 9.95% 77% C+ 62% D
Total Return 4.02% 27% F 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 24.56% 24% F 42% F
Risk Adjusted Return 40.51% 68% D+ 58% F
Market Capitalization 1.61B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Asset Management) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.60 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector